Breast Cancer Clinical Trials in San Antonio

Showing 41-60 of 397 trials

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

NCT07029399

The goal of this open-label dose escalation and expansion study is to evaluate the safety and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast cancer and solid tumors with CCNE1 amplification). Main questions to answer include: * What is the recommended dose for expansion and/or Phase 2 * What medical issues/symptoms do participants experience when taking NKT5097

HR+ Breast CancerTriple Negative Breast Cancer (TNBC)CCNE1 Amplified Advanced Solid Tumors+4 more

NiKang Therapeutics, Inc.205 participantsStarted Mar 2025

La Jolla, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +11 more locations

RECRUITINGPhase 3< 1 mile

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

NCT04862663

A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292)

Locally Advanced (Inoperable) or Metastatic Breast Cancer

AstraZeneca895 participantsStarted May 2021

Tucson, Arizona, United States • Fountain Valley, California, United States • Glendale, California, United States +280 more locations

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Breast Cancer Trials in Other Cities

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)

A Study of LY4175408 in Participants With Advanced Cancer

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Mobile Health for Adherence in Breast Cancer Patients

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Other Conditions in San Antonio